Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus Dosing for Cystic Lymphatic Malformations
NCT06673290Phase 3Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Nov 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sirolimus in cystic lymphatic malformation (CLM), sponsored by West China Hospital of Sichuan University. Started Nov 2024; status: recruiting.
02
Drugs
sirolimus
03
Conditions
cystic lymphatic malformation (CLM)
Beyond the preview
Go deeper on NCT06673290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06673290.